Plandaí Biotechnology, Inc. (PLPL)
Plandaí Biotechnology, Inc. operates in the Shell Companies industry of the Financial Services sector, headquartered in Taipei, TP, TW. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $448,895. On trailing twelve-month figures it carries a trailing P/E of -7.46, a net margin of 0.0%. Its beta of 9.73 implies it has historically moved more than the broad market.
Plandaí Biotechnology, Inc. specializes in developing distinctive botanical extracts intended for the nutriceutical and pharmaceutical industries. A primary focus is the development of its Phytofare Catechin Complex, an extract originating from green tea cultivated at the Senteeko Tea Estate in Mpumalanga, South Africa. The company is also advancing its Phytofare citrus complex, a citrus-based extract, alongside extracts derived from tomato fruit, Artemisia, and cannabis. Beyond its biotechnological pursuits, Plandaí operates agricultural holdings in South Africa, where it produces and sells timber and various other farm products. The company's corporate base is in London, United Kingdom.
Plandaí Biotechnology, Inc. is most often compared with the following Financial Services names: